Correction to: Nature Reviews Drug Discovery https://doi.org/10.1038/s41573-023-00735-0, published online 13 July 2023.
In the version of the article initially published, the name of the drug rezpegaldesleukin was misspelt in Fig. 1, Tables 1 and 2, and the main text. The name of the drug roflumilast was also misspelt in Fig. 1. The errors have been corrected in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bieber, T. Author Correction: Disease modification in inflammatory skin disorders: opportunities and challenges. Nat Rev Drug Discov 22, 935 (2023). https://doi.org/10.1038/s41573-023-00790-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41573-023-00790-7
